Richardson Linda M 4
4 · Altimmune, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
Richardson Linda M
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2025-09-16+96,000→ 96,000 total→ Common Stock, par value $0.0001 (96,000 underlying) - Award
Stock Options (option to buy)
2025-09-16+278,000→ 278,000 totalExercise: $3.63Exp: 2035-09-16→ Common Stock, par value $0.0001 (278,000 underlying)
Footnotes (3)
- [F1]The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on September 16, 2026, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested
- [F3]The RSUs become vested over four (4) years with 25% of the shares vesting September 16, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.